PNS355 HOW INVOLVED SHOULD PAYERS BE IN THE DEVELOPMENTS OF TARGET PRODUCT PROFILE (TPP), PRODUCT DEVELOPMENT PLAN (PDP) AND DESIGN OF CLINICAL TRIALS (DOCT)
Nov 1, 2019, 00:00
10.1016/j.jval.2019.09.2255
https://www.valueinhealthjournal.com/article/S1098-3015(19)34633-9/fulltext
Title :
PNS355 HOW INVOLVED SHOULD PAYERS BE IN THE DEVELOPMENTS OF TARGET PRODUCT PROFILE (TPP), PRODUCT DEVELOPMENT PLAN (PDP) AND DESIGN OF CLINICAL TRIALS (DOCT)
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(19)34633-9&doi=10.1016/j.jval.2019.09.2255
First page :
Section Title :
Open access? :
No
Section Order :
11961